Market Overview

The Global Biosimilars Market was valued at USD 37,654.5 million in 2023 and is expected to reach USD 142,500.5 million by 2031 while growing at a CAGR of 18.1% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global Biosimilars market growth. Biosimilars, akin to their reference biologic medicines, maintain high similarity without clinically significant differences in safety, purity, and potency. Unlike generic drugs, which mirror their small-molecule references precisely, biosimilars diverge due to the complexity of biological molecules and current manufacturing technology constraints.

The biosimilars market is propelled by the growing demand for cost-effective treatment and increasing healthcare expenditure, yet hindered by clinical challenges and intellectual property issues.

Furthermore, the global Biosimilars industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Product Class Analysis

The Global Biosimilars Market is segmented among Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-Inflammatory Agents, and Other Product Classes, based on Product Class. In 2023, Monoclonal Antibodies accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Application Analysis

The Global Biosimilars Market is segmented among Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Oncology, and Other Applications, based on Application. In 2023, Oncology accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Biosimilars Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Novartis AG, Pfizer Inc., Dr. Reddy's Laboratories Ltd, Amgen Inc., Eli Lily and Company, Coherus Biosciences, Inc., and Samsung Bioepies Co., Ltd

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Biosimilars Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Biosimilars Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Biosimilars Market Segmentation, By Product Class

• Global Biosimilars Market Share Analysis, By Product Class

• Global Biosimilars Market Growth Analysis, By Product Class

• Global Biosimilars Market Trends, By Product Class

o Monoclonal Antibodies

o Recombinant Hormones

o Immunomodulators

o Anti-Inflammatory Agents

o Other Product Classes

6. Global Biosimilars Market Segmentation, By Application

• Global Biosimilars Market Share Analysis, By Application

• Global Biosimilars Market Growth Analysis, By Application

• Global Biosimilars Market Trends, By Application

o Blood Disorders

o Growth Hormonal Deficiency

o Chronic and Autoimmune Disorders

o Oncology

o Other Applications  

7. Global Biosimilars Market Segmentation, By Region

• Global Biosimilars Market Share Analysis, By Region

• Global Biosimilars Market Growth Analysis, By Region

• Global Biosimilars Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Novartis AG*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Pfizer Inc.

• Dr. Reddy's Laboratories Ltd

• Amgen Inc.

• Eli Lily and Company

• Coherus Biosciences, Inc.

• Samsung Bioepies Co., Ltd  

*Similar analysis will be provided for each company listed above.